AMANDA LAUGHLIN: Open Payments
NPI 1609181999 · YUKON, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,231 in 70 payments from 20 companies in 2025. Trend: 2023 $988 · 2024 $1,183 · 2025 $1,231
Food & beverage: $1,231
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $317 |
| GlaxoSmithKline, LLC. | 12 | $151 |
| PFIZER INC. | 8 | $140 |
| Lilly USA, LLC | 6 | $127 |
| Dexcom, Inc. | 4 | $91 |
| SHIELD THERAPEUTICS INC | 2 | $64 |
| Organon LLC | 3 | $52 |
| Novartis Pharmaceuticals Corporation | 2 | $40 |
| Novo Nordisk Inc | 2 | $38 |
| Exact Sciences Corporation | 2 | $34 |
Products named: UBRELVY, TRELEGY ELLIPTA, QULIPTA, Dexcom G6 Transmitter, PREVNAR 20, JARDIANCE, VRAYLAR, ACCRUFER.
Industry payments across OK — which companies pay providers there.
